NASDAQ · IINN
Inspira Technologies OXY B.H.N. Ltd.
$1.05-$0.01 (-0.94%)
Inspira Technologies OXY B.H.N. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
Loading market information…
NASDAQ · LFWD · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Lifeward Ltd.’s quoted price sits in the lower half of its reported 52-week range, 38.5% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Lifeward Ltd.’s next earnings report is currently expected on Nov 13, 2026, with estimated earnings per share of -$0.79. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Lifeward Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Lifeward Ltd. is a healthcare technology company specializing in the creation, development, and commercialization of wearable robotic exoskeletons. These sophisticated devices are engineered to restore lower limb mobility for individuals living with spinal cord injuries (SCI), granting them the ability to stand, walk, pivot, and navigate staircases by providing assistive hip and knee motion. Key offerings from the company include the ReWalk Exo-Suit and the ReWalk Personal 6.0. Founded by Amit Goffer on June 20, 2001, the enterprise maintains its corporate headquarters in Marlborough, Massachusetts.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:13 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 |
|---|
| May 15, 2025 |
| -$5.52-39.39% vs estimate |
| $5.03M-13.8% vs estimate |
| Q4 2024 | Mar 7, 2025 | -$20.76-765.0% vs estimate | $7.55M-3.73% vs estimate |
|---|
| Q3 2024 | Nov 12, 2024 | -$4.20-29.63% vs estimate | $6.13M-27.4% vs estimate |
|---|
THE ANALYST VIEW
5 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 1 contributors · Median target $10.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.05-$0.01 (-0.94%)
Inspira Technologies OXY B.H.N. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$1.72-$0.02 (-1.15%)
Sintx Technologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 61.43% below the high.
$0.98-$0.04 (-3.91%)
IN8bio, Inc.’s quoted price sits in the lower half of its reported 52-week range, 64.1% below the high.
$3.33+$0.22 (+7.07%)
Sunshine Biopharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.28% below the high.
$0.28-$0.02 (-5.73%)
Pheton Holdings Ltd Class A Ordinary Shares’s quoted price sits in the lower half of its reported 52-week range, 99.12% below the high.
$1.73-$0.01 (-0.57%)
TransCode Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 86.27% below the high.
$2.31-$0.05 (-2.12%)
Beyond Air, Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.66% below the high.
$2.29+$0.03 (+1.33%)
Tenon Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.97% below the high.
